MSMahfuza Afroz Soma

Mahfuza Afroz Soma

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mahfuza Afroz Soma has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Quantification and Evaluation of Thiamine and Riboflavin in Marine Resources of the Bay of Bengal

    by Fahima Aktar, Naymor Rahaman, Hasina Akhter Simol, Mahfuza Afroz Soma, Zakir Sultan

    Seaweeds provide a range of crucial vitamins, among them water-soluble B complex vitamins such as thiamine (vitamin B1) and riboflavin (vitamin B2). The study focuses on the accurate quantification of thiamine and riboflavin in seaweed samples through an accurate and precise analytical process involving acid and enzymatic hydrolysis followed by HPLC analysis with a fluorescence detector. The applied methods were very accurate and precise as it performed recovery percentage about 99.06% for thiamine and 95.81% for riboflavin and RSD percentage less than 2% on average. Our findings reveal significant levels of thiamine and riboflavin present in the seaweeds which emphasis the nutritional value of seaweeds. Our study says that seaweeds contain up to 2.3 mg thiamin /100g and 0.9 mg riboflavin/100 g. The level of vitamins content varied with the variety of species and the environmental condition. Although with relatively lower riboflavin content, Seaweeds are very good source of vitamins. This study highlights the nutritional value of seaweeds which can be consider as powerhouse in nutritional context. Further exploration into other vitamins (water and fat soluble) and essential minerals would enhance our understanding of their nutritional significance.


  • Open Access

    Investigation of biological activities of Xeromphis uliginosa (Retz.) root extracts in Swiss-albino mice model, an extinctive medicinal plant of Bangladesh

    by Asma Aul Husna Pinkey, Zahirul Islam Khan, Rashaduzzaman Razu, Farhana Sultana Mitu, Mahfuza Afroz Soma

    Xeromphis. uliginosa (Retz.) is an extinctive Bangladeshi medicinal plant that is locally used for the treatments of pain, diabetes, diarrhea, depressant, and other diseases. The present study was conducted to evaluate the peripheral analgesic activity (PAA), central analgesic activity (CAA), central nervous system antidepressant activity (CNS-AD), antidiarrheal activity (ADA), and hypoglycaemic activity (HGA) of methanolic root extract of X. uliginosa (MREXU) in a mice model. The acetic acid-induced writhing inhibition and tail flick method were applied to determine the PAA and CAA of MREXU. The CNS-AD was measured using the phenobarbitone sodium-mediated sleeping method whereas, the castor oil-induced antidiarrheal method was used to determine the ADA of the crude extracts. To determine the HGA of MREXU crude extract, the tail tipping technique was conducted in a mice model. The MREXU displayed potential PAA and CAA in mice models. The MREXU 200 and 400 mg/kg significantly inhibit the number of writings along with diclofenac sodium. On the other hand, MREXU both doses significantly inhibit thermal stimulus after 60 and 90 minutes respectively. In the CNS-AD study, crude extract of 200 and 400 mg/kg significantly increase the onset of sleep by decreasing the duration of sleep. Similarly, the dose of 200 mg/kg significantly reduced diarrheal faeces for the whole 4 hours of experiments. The heartiest outcome of MREXU was displayed in the HGA assay. Both doses of MREXU significantly reduced the blood sugar level for the entire 3 hours of the experiments. In this study, it is revealed that the root of MREXU has extremely significant blood sugar-reducing activity, potential CNS-AD and mild to moderate nociceptive activity in the mice model

  • Open Access

    Analgesic, Hypoglycemic and Antidiarrheal Activities Screening of Canna indica L.

    by Nahid Sultana, Mahfuza Afroz Soma, Abdur Rashid

    The rhizome of Canna indica L. (family: Cannaceae) was extracted in methanol and two doses- 200 and 400 mg/kg body weight of the extract were employed to reveal central and peripheral analgesic, hypoglycemic and antidiarrheal properties in vivo. According to tail immersion technique, both doses significantly rose the time of latent response for 90 minutes compared to control mice group in assessing central analgesia. Acetic acid-induced writhing process demonstrated 37.29% and 64.41% inhibition of mice movement at both doses, respectively which indicated promising and statistically significant peripheral analgesic effect. On the other hand, hypoglycemic and antidiarrheal activities maintained dose and time dependent manner. Moreover, the extract of rhizome displayed statistically significant antidiarrheal activity at 400 mg/kg b.w. dose. Bangladesh Pharmaceutical Journal 25(2): 137-142, 2022 (July)


  • Open Access

    ELAEOCARPUS SERRATUS L. EXHIBITS POTENTIAL ANALGESIC AND ANTIDIARRHEAL ACTIVITIES IN MICE MODEL

    by A. A. H. Pinkey, Z. I. Khan, M. A. Taher, M. A. Soma

    Background. Elaeocarpus serratus L. (Family: Elaeocarpaceae) is a tropical fruit tree, traditionally used in the treatments of poisoning, diarrhea, arthritis, and other diseases. Objectives. The current study was performed to conduct the analgesic, antidiarrheal, and hypoglycemic activity of E. serratus in mice model using methanolic bark crude extract. Methods. To assess the peripheral and central analgesic activity, the acetic acid-induced writhing and tail immersion methods were respectively used. The castor-oil mediated antidiarrheal method was used to assess the antidiarrheal activity whereas, the tail tipping technique was conducted to determine the hypoglycemic activity of the plant extract. Results. In the peripheral analgesic assay, the methanolic bark crude extract of E. serratus significantly inhibits the number of writing 69.77% (200 mg/kg) and 73.26% (400 mg/kg) respectively (p<0.05) which was strongly comparable with standard NSAID drug diclofenac sodium 75.58% (p<0.05). Similarly, it shown a significant tail flicking response for 30 minutes, 60 minutes and 90 minutes of central analgesic activity assay. In antidiarrheal activity assay, the E. serratus substantially reduced the number of diarrheal feces 64.26% (200 mg/kg, p<0.05) and 78.57% (400 mg/kg, p<0.05) which was also comparable with the positive control loperamide. The hypoglycemic activity of E. serratus extract was not convincing. Conclusions. Our investigation demonstrated the significant analgesic and antidiarrheal activities of methanolic bark extract of E. serratus (200 and 400 mg/kg) in mice model.